Elev8 Brands, Inc. Retires 275 Million Shares of Common Stock
May 12 2017 - 8:30AM
InvestorsHub NewsWire
Elev8 Brands, Inc. Retires 275 Million Shares of Common
Stock
ROCKLEDGE, FL -- May 12, 2017 --
InvestorsHub NewsWire -- Elev8 Brands, Inc. (OTC Pink:VATE), a
holding company focused on the commercial development of hemp and
CBD-based products including hemp coffee, tea, and E-juices which
target the health and wellness markets, announces
the retirement of 275 million (275,000,000)
shares of common stock.
The company successfully negotiated through a
private transaction the retirement of these shares which will
improve the capital structure and overall health of the
company. The effective date of the transaction is May
18th, 2017.
Chief Executive Ryan Medico stated, “The return
of these shares to the treasury instantly adds value to
shareholders and demonstrates our desire to maintain a strong and
healthy capital structure. Our upcoming quarterly report will
reflect the retired shares, as well as update the current share
structure.”
The Company is also excited to announce that the
newly formulated hemp coffee flavors Hazelnut Crème and French
Vanilla are now available for purchase on Amazon.com.
Medico concluded, “Elev8 Brands, Inc. continues
to hit milestones set in our aggressive growth plans and we look
forward to the next growth phase. After very successful meetings
with Mr. Shuman and Mr. Silverstein this week in Colorado, we are
set to expand our product line to enter into various vertical
markets as well as continue to acquire synergistic companies. Elev8
is set to become a conglomerate in the Hemp industry, focusing on
various product lines that will help increase value for our
shareholders.”
Elev8 recently announced that Tom Shuman joined
Elev8 Brands, Inc. as a senior consultant. Tom Shuman is an
ex-professional athlete that has parlayed his competitive nature
into a tremendously successful Senior Level Sales & Marketing
Executive with experience and expertise in Building Corporate
Value. Whether challenged to accelerate growth within a mature
business market, orchestrate an aggressive turnaround, or launch a
new brand or product, Tom and his Sales & Marketing teams have
consistently delivered strong operating and financial
results.
About Elev8 Brands, Inc.:
Elev8 Brands, Inc. specializes in the development
and marketing of products for the fitness and wellness
markets. The company is founded on the basis of creating
high-quality, sustainable, products for health conscious
consumers.
About Elev8 Hemp LLC:
Elev8 Hemp LLC is a wholly-owned subsidiary of
Elev8 Brands, Inc. which focuses on the development and marketing
of hemp-based food, beverage, and health care products including
hemp coffee, hemp water, and hemp-based skin care
products.
About 02 Breathe LLC:
02 Breathe is a wholly-owned subsidiary of Elev8
Brands, Inc. which focuses on their oxygen bar while bringing in an
array of CBD products. O2 Breathe carries CBD tinctures, CBD vape,
CBD lotions and message products. 02 Breathe is currently looking
to offer CBD at their oxygen bar.
Please visit,www.elev8hemp.com for
more information
Safe Harbor Statement:
The information posted in this release may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. You can identify
these statements by use of the words "may," "will," "should,"
"plans," "expects," "anticipates," "continue," "estimate,"
"project," "intend," and similar expressions. Forward-looking
statements involve risks and uncertainties that could cause actual
results to differ materially from those projected or anticipated.
These risks and uncertainties include, but are not limited to,
general economic and business conditions, effects of continued
geopolitical unrest and regional conflicts, competition, changes in
technology and methods of marketing, delays in completing various
engineering and manufacturing programs, changes in customer order
patterns, changes in product mix, continued success in
technological advances and delivering technological innovations,
shortages in components, production delays due to performance
quality issues with outsourced components, and various other
factors beyond the Company's control.